Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue
Applied Biosciences · 10.08.2026 · 5 (3) · 69
DOI: 10.3390/applbiosci5030069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biosciences, online erschienen am 10.08.2026. Verfasst von Wushan T. Jayalath und 4 weiteren Autor:innen. Die Arbeit nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Organization for Women in Science for the Developing World, UNESCO-TWAS.
Themen: Demenz
Abstract (Originalsprache)
Globally, over 55 million people are affected by Alzheimer’s disease (AD), a number that is increasing rapidly and projected to triple by 2050. AD is a type of neurodegenerative disorder for which there is no curative treatment. The accumulation of amyloid-β (Aβ) plaques and the formation of neurofibrillary tangles are the hallmarks of AD. Curcumin, a bioactive compound extracted from turmeric rhizomes, has shown significant neuroprotective properties, including anti-amyloidogenic, anti-inflammatory, antioxidant, and metal-chelating. Though much research has revealed the potential of curcumin as a promising therapeutic agent for AD, the limited bioavailability of curcumin restricts its effectiveness in pharmaceutical applications. To overcome this challenge, nanocarrier-based delivery systems have emerged as a promising strategy for enhancing the bioavailability and therapeutic efficacy of curcumin. This review provides an overview of recent findings on curcumin-based nanocarriers for AD therapy.
Förderung
- Organization for Women in Science for the Developing World
- UNESCO-TWAS
Zitieren
APA
Jayalath, W. T., Gunaratna, M. J., Kadigamuwa, C. C., Thambiliyagodage, C., & Dahanayake, J. N. (2026). Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue. Applied Biosciences, 5(3), 69. https://doi.org/10.3390/applbiosci5030069
Vancouver
Jayalath WT, Gunaratna MJ, Kadigamuwa CC, Thambiliyagodage C, Dahanayake JN. Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue. Applied Biosciences. 2026;5(3):69. doi:10.3390/applbiosci5030069
BibTeX
@article{Jayalath2026,
author = {Jayalath, Wushan T. and Gunaratna, Medha J. and Kadigamuwa, Chamila C. and Thambiliyagodage, Charitha and Dahanayake, Jayangika N.},
title = {Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue},
journal = {Applied Biosciences},
year = {2026},
volume = {5},
number = {3},
pages = {69},
doi = {10.3390/applbiosci5030069}
}
EUVIMED